Cargando…

Triggers of Guillain–Barré Syndrome: Campylobacter jejuni Predominates

Guillain–Barré syndrome (GBS) is a rare immune-mediated acute polyradiculo-neuropathy that typically develops after a previous gastrointestinal or respiratory infection. This narrative overview aims to summarise and discuss current knowledge and previous evidence regarding triggers and pathophysiolo...

Descripción completa

Detalles Bibliográficos
Autor principal: Finsterer, Josef
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9696744/
https://www.ncbi.nlm.nih.gov/pubmed/36430700
http://dx.doi.org/10.3390/ijms232214222
_version_ 1784838387082985472
author Finsterer, Josef
author_facet Finsterer, Josef
author_sort Finsterer, Josef
collection PubMed
description Guillain–Barré syndrome (GBS) is a rare immune-mediated acute polyradiculo-neuropathy that typically develops after a previous gastrointestinal or respiratory infection. This narrative overview aims to summarise and discuss current knowledge and previous evidence regarding triggers and pathophysiology of GBS. A systematic search of the literature was carried out using suitable search terms. The most common subtypes of GBS are acute inflammatory demyelinating polyneuropathy (AIDP) and acute motor axonal neuropathy (AMAN). The most common triggers of GBS, in three quarters of cases, are previous infections. The most common infectious agents that cause GBS include Campylobacter jejuni (C. jejuni), Mycoplasma pneumoniae, and cytomegalovirus. C. jejuni is responsible for about a third of GBS cases. GBS due to C. jejuni is usually more severe than that due to other causes. Clinical presentation of GBS is highly dependent on the structure of pathogenic lipo-oligosaccharides (LOS) that trigger the innate immune system via Toll-like-receptor (TLR)-4 signalling. AIDP is due to demyelination, whereas in AMAN, structures of the axolemma are affected in the nodal or inter-nodal space. In conclusion, GBS is a neuro-immunological disorder caused by autoantibodies against components of the myelin sheath or axolemma. Molecular mimicry between surface structures of pathogens and components of myelin or the axon is one scenario that may explain the pathophysiology of GBS.
format Online
Article
Text
id pubmed-9696744
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-96967442022-11-26 Triggers of Guillain–Barré Syndrome: Campylobacter jejuni Predominates Finsterer, Josef Int J Mol Sci Review Guillain–Barré syndrome (GBS) is a rare immune-mediated acute polyradiculo-neuropathy that typically develops after a previous gastrointestinal or respiratory infection. This narrative overview aims to summarise and discuss current knowledge and previous evidence regarding triggers and pathophysiology of GBS. A systematic search of the literature was carried out using suitable search terms. The most common subtypes of GBS are acute inflammatory demyelinating polyneuropathy (AIDP) and acute motor axonal neuropathy (AMAN). The most common triggers of GBS, in three quarters of cases, are previous infections. The most common infectious agents that cause GBS include Campylobacter jejuni (C. jejuni), Mycoplasma pneumoniae, and cytomegalovirus. C. jejuni is responsible for about a third of GBS cases. GBS due to C. jejuni is usually more severe than that due to other causes. Clinical presentation of GBS is highly dependent on the structure of pathogenic lipo-oligosaccharides (LOS) that trigger the innate immune system via Toll-like-receptor (TLR)-4 signalling. AIDP is due to demyelination, whereas in AMAN, structures of the axolemma are affected in the nodal or inter-nodal space. In conclusion, GBS is a neuro-immunological disorder caused by autoantibodies against components of the myelin sheath or axolemma. Molecular mimicry between surface structures of pathogens and components of myelin or the axon is one scenario that may explain the pathophysiology of GBS. MDPI 2022-11-17 /pmc/articles/PMC9696744/ /pubmed/36430700 http://dx.doi.org/10.3390/ijms232214222 Text en © 2022 by the author. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Finsterer, Josef
Triggers of Guillain–Barré Syndrome: Campylobacter jejuni Predominates
title Triggers of Guillain–Barré Syndrome: Campylobacter jejuni Predominates
title_full Triggers of Guillain–Barré Syndrome: Campylobacter jejuni Predominates
title_fullStr Triggers of Guillain–Barré Syndrome: Campylobacter jejuni Predominates
title_full_unstemmed Triggers of Guillain–Barré Syndrome: Campylobacter jejuni Predominates
title_short Triggers of Guillain–Barré Syndrome: Campylobacter jejuni Predominates
title_sort triggers of guillain–barré syndrome: campylobacter jejuni predominates
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9696744/
https://www.ncbi.nlm.nih.gov/pubmed/36430700
http://dx.doi.org/10.3390/ijms232214222
work_keys_str_mv AT finstererjosef triggersofguillainbarresyndromecampylobacterjejunipredominates